Esophageal malignancy: a growing concern

World J Gastroenterol. 2012 Dec 7;18(45):6521-6. doi: 10.3748/wjg.v18.i45.6521.

Abstract

Esophageal cancer is mainly found in Asia and east Africa and is one of the deadliest cancers in the world. However, it has not garnered much attention in the Western world due to its low incidence rate. An increasing amount of data indicate that esophageal cancer, particularly esophageal adenocarcinoma, has been rising by 6-fold annually and is now becoming the fastest growing cancer in the United States. This rise has been associated with the increase of the obese population, as abdominal fat puts extra pressure on the stomach and causes gastroesophageal reflux disease (GERD). Long standing GERD can induce esophagitis and metaplasia and, ultimately, leads to adenocarcinoma. Acid suppression has been the main strategy to treat GERD; however, it has not been proven to control esophageal malignancy effectively. In fact, its side effects have triggered multiple warnings from regulatory agencies. The high mortality and fast growth of esophageal cancer demand more vigorous efforts to look into its deeper mechanisms and come up with better therapeutic options.

Keywords: Esophageal cancer; Gastroesophageal reflux disease; Obesity.

Publication types

  • Editorial
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenocarcinoma / diagnosis*
  • Adenocarcinoma / epidemiology*
  • Animals
  • Bile Acids and Salts / chemistry
  • China
  • Esophageal Neoplasms / diagnosis*
  • Esophageal Neoplasms / epidemiology*
  • Esophagus / pathology
  • Gastroesophageal Reflux / diagnosis
  • Gastroesophageal Reflux / epidemiology
  • Humans
  • Inflammation
  • Obesity / complications
  • Obesity / diagnosis
  • Rats
  • United States

Substances

  • Bile Acids and Salts